Bottom line
Is LMEAX a good fund? The bottom line
LMEAX is the Class A share class of Franklin International Equity Fund, an actively managed international stock mutual fund from Franklin Templeton.
Its expense ratio is 1.28% — about $128 a year on every $10,000 invested, more expensive than 80% of international stock funds we track.
It returned +25.8% over one year, +9.2% a year over five years, +7.2% a year over ten (as of Dec 31, 2025, per its prospectus).
With $345 million in net assets and 169 holdings, its largest position is Asml Holding Nv (4.3%) and the top 10 make up 19.9% of the portfolio.
This share class carries a front-end sales charge of up to 5.5%; a no-load class or ETF alternative can avoid it.
The closest lower-cost alternative we found is EFAX (0.2%, 60% top-holdings overlap).
What stands out
- 5-year return beat 77% of category peers
What to watch
- Expensive for its category (1.28%)
- Front-end sales load up to 5.5%
- 12b-1 marketing fee of 0.25% a year
Updated Nov 19, 2026
What LMEAX invests in
Maximum long-term total return.
Under normal circumstances, the fund intends to invest primarily (at least 65% of its total assets) in equity securities of issuers located outside the United States. Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowing for investment purposes, in equity securities. The subadviser uses a quantitative process and seeks to add value through stock selection and region, country and sector allocation. Region, country and sector allocations are based on rankings generated by the subadvisers proprietary models. The subadviser periodically reviews these allocations and may adjust them based on current or anticipated market conditions or in an effort to manage risk consistent with the funds investment objective. The fund is not limited in the amount of its total assets that may be denominated in a single currency or invested in securities of issuers…
From the fund's prospectus (filed Jan 27, 2026).
LMEAX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| LMEAX | +25.8% | +9.2% | +7.2% |
| International Stock median | +25.5% | +6.4% | +7.6% |
Source: Fund prospectus, as of Dec 31, 2025
What LMEAX costs
On a $10,000 investment, LMEAX's 1.28% expense ratio costs about $128 a year. The prospectus estimates $2,021 in total costs over 10 years (assuming 5% annual returns). The median international stock fund charges 0.9%.
LMEAX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Asml Holding Nv ASML | 4.28% |
| 2 | Hsbc Holdings Plc HSBA | 2.03% |
| 3 | Roche Holding Ag ROP | 1.92% |
| 4 | Novartis Ag NOVN | 1.89% |
| 5 | Tokyo Electron Ltd 8035 | 1.77% |
| 6 | Astrazeneca Plc AZN | 1.77% |
| 7 | Banco Santander Sa SAN | 1.64% |
| 8 | Nestle' Sa/ag NESN | 1.59% |
| 9 | Bhp Group Ltd BHP | 1.51% |
| 10 | Advantest Corp 6857 | 1.47% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 19.9% of the fund. See all top 25 holdings and asset mix →